Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Helix BioPharma (TSE:HBP)
TSX:HBP
Helix BioPharma (HBP) Stock Price & Analysis
23 Followers
HBP Stock Chart & Stats
Day’s RangeC$0.2 - C$0.2
52-Week Range― - ―
Previous CloseC$0.19
Volume1.01K
Average Volume (3M)N/A
Market Cap
C$43.33M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
Jun 11, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Helix BioPharma News
PremiumCompany Announcements
Helix BioPharma Corp. Progresses Amid Delays
PremiumCompany Announcements
Helix BioPharma Completes $1.9M Private Placement
PremiumCompany Announcements
Helix BioPharma Corp. Secures New Funding
PremiumCompany Announcements
Helix BioPharma Initiates Private Share PlacementOptions Prices
Currently, No data available
---
Ownership Overview
35.76% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
64.24% Public Companies and
Individual Investors
HBP FAQ
What was Helix BioPharma’s price range in the past 12 months?
Currently, no data Available
What is Helix BioPharma’s market cap?
Currently, no data Available
When is Helix BioPharma’s upcoming earnings report date?
Helix BioPharma’s upcoming earnings report date is Jun 11, 2024 which is in 53 days.
How were Helix BioPharma’s earnings last quarter?
Currently, no data Available
Is Helix BioPharma overvalued?
According to Wall Street analysts Helix BioPharma’s price is currently Overvalued.
Does Helix BioPharma pay dividends?
Helix BioPharma does not currently pay dividends.
What is Helix BioPharma’s EPS estimate?
Helix BioPharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Helix BioPharma have?
Currently, no data Available
What happened to Helix BioPharma’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Helix BioPharma?
Currently, no hedge funds are holding shares in TSE:HBP
---
Helix BioPharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-3.84%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-60.53%
Trailing 12-Months
Company Description
Helix BioPharma
Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidates are Tumor Defence Breaker L-DOS47, and, V-DOS47 among others.
---
Technical Analysis
---